Release date: 26 June 2017
Promoter – Financial Intermediary
LABORATORIOS FARMACEUTICOS ROVI SALocation
Description
The project concerns the promoter's research, development and innovation (RDI) activities for various drug-delivery technologies, including preclinical development and clinical studies.
Objectives
ROVI's pharmacological investigations involved in the project strengthen ROVI's innovativeness and help the company to maintain its competitive edge and expand its international footprint.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 45 million
Total cost (Approximate amount)
EUR 94 million
Environmental aspects
The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation, as appropriate.
Procurement
The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation.
Status
Signed - 21/12/2017
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).